Sizing composition for reinforcing fibres and applications thereof
US-2016355645-A1 · Dec 8, 2016 · US
US10155065B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10155065-B2 |
| Application number | US-201415104193-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 12, 2014 |
| Priority date | Dec 13, 2013 |
| Publication date | Dec 18, 2018 |
| Grant date | Dec 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject matter of the present invention is a photopolymerizable liquid composition comprising at least one epoxidized polybutadiene prepolymer, at least one cationic photoinitiator, and at least one thioxanthone-derived photosensitizer, which can, for example, be in the form of a liquid dressing. The subject matter of the invention is also a process for obtaining a polymerized film from said photopolymerizable liquid composition, characterized in that said composition is applied to tissues such as the skin, the skin appendages or the mucous membranes so as to form a uniform liquid film, and the film thus obtained is subjected to ultraviolet radiation, preferably ultraviolet-visible radiation having a wavelength of between 380 and 405 nm, preferably between 385 and 395 nm.
Opening claim text (preview).
The invention claimed is: 1. A method of covering tissue with a polymerized film made from a polymerization liquid composition comprising: at least one epoxidized polybutadiene prepolymer, at least one cationic onium salt photoinitiator, and at least one thioxanthone derivative photosensitizer, wherein said method comprises i. applying said composition to said tissue so as to form a uniform liquid film, and ii. subjecting the film obtained in step i. to UV-visible radiation having a wavelength of between 380 and 405 nm; and wherein said tissue is the skin, the skin appendages or mucous membranes. 2. The method of claim 1 wherein the thickness of the uniform liquid film is greater than 500 nm. 3. The method of claim 1 , wherein the film obtained in step i. is subjected to UV-visible radiation, for a period of between 5 seconds and 60 minutes. 4. The method of claim 1 wherein the thickness of the uniform liquid film is between 1 and 300 μm. 5. The method of claim 1 wherein the thickness of the uniform liquid film is between 2 and 200 μm. 6. The method of claim 1 , wherein said UV-visible radiation has a wavelength of between 385 and 395 nm. 7. The method of claim 1 , wherein the photopolymerizable liquid composition further comprises a second prepolymer. 8. The method of claim 7 , wherein the second prepolymer is a vegetable oil of natural origin functionalized with at least one cationically polymerizable epoxide group. 9. The method of claim 7 , wherein the second prepolymer is selected from the group consisting of epoxidized almond oil, epoxidized peanut oil, epoxidized argan oil, epoxidized rapeseed oil, epoxidized coconut oil, epoxidized linseed oil, epoxidized corn oil, epoxidized mustard oil, epoxidized olive oil, epoxidized palm oil, epoxidized grapeseed oil, epoxidized castor oil, epoxidized sesame oil, epoxidized soybean oil, epoxidized sunflower oil, and mixtures thereof. 10. The method of claim 1 , wherein the photopolymerizable liquid composition further comprises a hydrogen-donor compound. 11. The method of claim 10 , wherein the hydrogen-donor compound is a primary, secondary or tertiary alcohol. 12. The method of claim 10 , wherein the hydrogen-donor compound is selected from the group consisting of n-propanol, isopropanol, benzyl alcohol, t-butanol, and mixtures thereof.
Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence) · CPC title
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
Mixtures of macromolecular compounds · CPC title
obtained by epoxidation of unsaturated precursor, e.g. polymer or monomer · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.